vs
Side-by-side financial comparison of CBAK Energy Technology, Inc. (CBAT) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $58.8M, roughly 1.3× CBAK Energy Technology, Inc.). On growth, CBAK Energy Technology, Inc. posted the faster year-over-year revenue change (131.8% vs 27.7%). CBAK Energy Technology, Inc. produced more free cash flow last quarter ($16.1M vs $14.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -0.0%).
CBAK Energy Technology, Inc. is a global supplier of lithium-ion battery products including high-performance cells, modules and battery packs. It serves key segments such as electric vehicles, stationary energy storage systems and consumer electronics, with core operations in China and a worldwide customer base.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
CBAT vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $58.8M | $75.5M |
| Net Profit | $-7.4M | — |
| Gross Margin | 7.3% | 69.3% |
| Operating Margin | -13.6% | 22.7% |
| Net Margin | -12.5% | — |
| Revenue YoY | 131.8% | 27.7% |
| Net Profit YoY | -63.6% | — |
| EPS (diluted) | $-0.08 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $58.8M | $75.5M | ||
| Q3 25 | $60.9M | $54.5M | ||
| Q2 25 | $40.5M | $52.4M | ||
| Q1 25 | $34.9M | $46.0M | ||
| Q4 24 | $25.4M | $59.1M | ||
| Q3 24 | $44.6M | $80.5M | ||
| Q2 24 | $47.8M | $47.1M | ||
| Q1 24 | $58.8M | $43.8M |
| Q4 25 | $-7.4M | — | ||
| Q3 25 | $2.7M | $8.8M | ||
| Q2 25 | $-3.1M | $5.9M | ||
| Q1 25 | $-1.6M | $3.0M | ||
| Q4 24 | $-4.5M | — | ||
| Q3 24 | $17.6K | $20.3M | ||
| Q2 24 | $6.4M | $-4.5M | ||
| Q1 24 | $9.8M | $-4.8M |
| Q4 25 | 7.3% | 69.3% | ||
| Q3 25 | 8.0% | 77.7% | ||
| Q2 25 | 11.0% | 76.5% | ||
| Q1 25 | 13.7% | 77.1% | ||
| Q4 24 | 13.1% | 76.4% | ||
| Q3 24 | 15.6% | 63.9% | ||
| Q2 24 | 26.6% | 77.4% | ||
| Q1 24 | 31.9% | 75.5% |
| Q4 25 | -13.6% | 22.7% | ||
| Q3 25 | -6.6% | 17.6% | ||
| Q2 25 | -8.7% | 12.7% | ||
| Q1 25 | -8.2% | 8.7% | ||
| Q4 24 | -26.0% | 22.6% | ||
| Q3 24 | -1.9% | 27.4% | ||
| Q2 24 | 12.4% | -4.6% | ||
| Q1 24 | 17.4% | -5.3% |
| Q4 25 | -12.5% | — | ||
| Q3 25 | 4.4% | 16.2% | ||
| Q2 25 | -7.6% | 11.2% | ||
| Q1 25 | -4.5% | 6.5% | ||
| Q4 24 | -17.8% | — | ||
| Q3 24 | 0.0% | 25.2% | ||
| Q2 24 | 13.5% | -9.6% | ||
| Q1 24 | 16.7% | -11.0% |
| Q4 25 | $-0.08 | $0.26 | ||
| Q3 25 | $0.03 | $0.17 | ||
| Q2 25 | $-0.03 | $0.12 | ||
| Q1 25 | $-0.02 | $0.06 | ||
| Q4 24 | $-0.05 | $0.40 | ||
| Q3 24 | $0.00 | $0.41 | ||
| Q2 24 | $0.07 | $-0.09 | ||
| Q1 24 | $0.11 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.3M | $97.5M |
| Total DebtLower is stronger | $4.1M | $22.7M |
| Stockholders' EquityBook value | $112.7M | $130.3M |
| Total Assets | $426.2M | $216.3M |
| Debt / EquityLower = less leverage | 0.04× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.3M | $97.5M | ||
| Q3 25 | $10.5M | $94.4M | ||
| Q2 25 | $45.7M | $96.0M | ||
| Q1 25 | $9.6M | $93.2M | ||
| Q4 24 | $11.0M | $101.0M | ||
| Q3 24 | $24.2M | $96.7M | ||
| Q2 24 | $44.1M | $96.8M | ||
| Q1 24 | $23.8M | $107.2M |
| Q4 25 | $4.1M | $22.7M | ||
| Q3 25 | $4.8M | $34.0M | ||
| Q2 25 | $4.9M | $45.3M | ||
| Q1 25 | $4.1M | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
| Q4 25 | $112.7M | $130.3M | ||
| Q3 25 | $121.4M | $115.3M | ||
| Q2 25 | $118.2M | $104.7M | ||
| Q1 25 | $120.8M | $97.1M | ||
| Q4 24 | $121.7M | $92.1M | ||
| Q3 24 | $131.2M | $71.1M | ||
| Q2 24 | $126.6M | $48.5M | ||
| Q1 24 | $120.9M | $51.0M |
| Q4 25 | $426.2M | $216.3M | ||
| Q3 25 | $363.9M | $202.9M | ||
| Q2 25 | $333.1M | $194.9M | ||
| Q1 25 | $311.5M | $196.2M | ||
| Q4 24 | $302.2M | $213.3M | ||
| Q3 24 | $293.5M | $220.7M | ||
| Q2 24 | $279.6M | $205.0M | ||
| Q1 24 | $286.5M | $214.1M |
| Q4 25 | 0.04× | 0.17× | ||
| Q3 25 | 0.04× | 0.30× | ||
| Q2 25 | 0.04× | 0.43× | ||
| Q1 25 | 0.03× | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $29.8M | $14.4M |
| Free Cash FlowOCF − Capex | $16.1M | $14.4M |
| FCF MarginFCF / Revenue | 27.3% | 19.1% |
| Capex IntensityCapex / Revenue | 23.4% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $3.9M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $29.8M | $14.4M | ||
| Q3 25 | $14.6M | $9.7M | ||
| Q2 25 | $13.8M | $14.1M | ||
| Q1 25 | $-9.6M | $3.6M | ||
| Q4 24 | $9.6M | $15.6M | ||
| Q3 24 | $19.7M | $11.0M | ||
| Q2 24 | $2.9M | $1.0M | ||
| Q1 24 | $7.4M | $11.2M |
| Q4 25 | $16.1M | $14.4M | ||
| Q3 25 | $6.0M | $9.7M | ||
| Q2 25 | $4.1M | $14.1M | ||
| Q1 25 | $-22.3M | $3.6M | ||
| Q4 24 | $3.9M | $15.6M | ||
| Q3 24 | $16.5M | $11.0M | ||
| Q2 24 | $2.5M | $1.0M | ||
| Q1 24 | $-454.0K | — |
| Q4 25 | 27.3% | 19.1% | ||
| Q3 25 | 9.9% | 17.7% | ||
| Q2 25 | 10.2% | 26.8% | ||
| Q1 25 | -63.9% | 7.7% | ||
| Q4 24 | 15.5% | 26.4% | ||
| Q3 24 | 37.1% | 13.7% | ||
| Q2 24 | 5.2% | 2.1% | ||
| Q1 24 | -0.8% | — |
| Q4 25 | 23.4% | 0.0% | ||
| Q3 25 | 14.1% | 0.0% | ||
| Q2 25 | 23.8% | 0.0% | ||
| Q1 25 | 36.3% | 0.1% | ||
| Q4 24 | 22.5% | 0.0% | ||
| Q3 24 | 7.0% | 0.0% | ||
| Q2 24 | 0.9% | 0.0% | ||
| Q1 24 | 13.4% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | 5.51× | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | 1115.72× | 0.54× | ||
| Q2 24 | 0.46× | — | ||
| Q1 24 | 0.76× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CBAT
| Manufacturing Lithium Batteries | $28.0M | 48% |
| Residential Energy Supply And Uninterruptable Supplies | $17.8M | 30% |
| Light Electric Vehicles | $12.9M | 22% |
| Precursor | $108.0K | 0% |
PBYI
Segment breakdown not available.
